Effects of orexin-A on memory processing

Peptides

Volumn 23, Issue 9, 2002, Pages 1683-1688

  Jaeger, Laura B ^a,c   Farr, Susan A ^a,b   Banks, William A ^a,b   Morley, John E ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Washington University   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Beta amyloid; Hypocretin; Memory; Mouse; Orexin A; Retention; SAMP8; T maze

Indexed keywords

AMYLOID BETA PROTEIN; OREXIN A;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; LEARNING DISORDER; MALE; MAZE TEST; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RETROGRADE AMNESIA; SHOCK;

AMYLOID BETA-PROTEIN; ANIMALS; AVOIDANCE LEARNING; BRAIN; CARRIER PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MAZE LEARNING; MEMORY; MICE; NEUROPEPTIDES; TIME FACTORS;

EID: 0036710301     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(02)00110-9     Document Type: Article

References (31)

1. Brown R.E., Sergeeva O., Eriksson K.S., Haas H.L. Orexin-A excites serotonergic neurons in the dorsal raphae nucleus of the rat. Neuropharmacology. 40(3):2001;457-459.
2. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C.E.et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 98:1999;437-451.
3. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kanagawa K.et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. U.S.A. 96:1999;748-753.
4. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E.et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U.S.A. 95:1998;322-327.
5. Elias C.F., Saper C.B., Maratos-Flier E., Tritos N.A., Lee C., Kelly J.et al. Chemically defined projections linking the medio-basal hypothalamus and the lateral hypothalamic area. J. Comp. Neurol. 402:1998;442-459.
6. Farr S.A., Banks W.A., LaScola M.E., Flood J.F., Morley J.E. Permanent and temporary inactivation of the hippocampus impairs T-maze footshock aviodance acquisition and retention. Brain. Res. 872(1-2):2000;242-249.
7. Farr S.A., Flood J.F., Morley J.E. The effect of cholinergic, GABAergic, serotonergic, and glutamatergic receptor modulation on posttrial memory processing in the hippocampus. Neurobiol. Learn. Mem. 73:2000;150-167.
8. Farr S.A., Uezu K., Flood J.F., Morley J.E. Septo-hippocampal drug interactions in post-trial memory processing. Brain. Res. 847:1999;221-230.
9. Flood J.F., Baker M.L., Hernandez E.N., Morley J.E. Modulation of memory processing by neuropeptide Y varies with brain injection site. Brain. Res. 503(1):1989;73-82.
10. Flood J.F., Farr S.A., Uezu K., Morley J.E. Age-related changes in septal, serotonergic, GABAergic and glutamatergic facilitation of retention in SAMP8 mice. Neurobiol. Learn. Mem. 105(1-2):1998;173-188.
11. Flood J.F., Harris F.J., Morley J.E. Age-related changes in hippocampal drug facilitation of memory processing in SAMP8 mice. Neurobiol Aging. 17(1):1996;15-24.
12. Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M.et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron. 30(2):2001;345-354.
13. Horvath T.L., Peyron C., Diano S., Ivanov A., Aston-Jones G., Kilduff T.S.et al. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J. Comp. Neurol. 415:1999;145-159.
14. Huang Z.-L., Qu W.-M., Li W.-D., Mochizuki T., Eguchi N., Watanabe T.et al. Arousal effect of orexin A depends on activation of the histaminergic system. Proc. Natl. Acad. Sci. U.S.A. 98(17):2001;9965-9970.
15. Izquierdo I., Bianchin M., Silva M.B.E., Zanatta M.S., Walz R., Ruschel A.C.et al. CNQX infused into rat hippocampus or amygdala disrupts the expression of memory of two different tasks. Behav. Neural. Biol. 59:1993;1-4.
16. Izquierdo I., Cunha C.D., Rosat R., Jerusalinsky D., Ferreira M.B.C., Medina J.H. Neurotansmitter receptors involved in post-training memory processing by the amygdala, medial septum, and hippocampus of the rat. Behav. Neural. Biol. 58:1992;16-26.
17. Kane J.K., Parker S.L., Matta S.G., Fu Y., Sharp B.M., Li M.D. Nicotine up-regulates expression of orexin and its receptors in rat brain. Endocrinology. 141(10):2000;3623-3629.
18. Kumar V.B., Farr S.A., Flood J.F., Kamlesh V., Franko M., Banks W.A.et al. Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides. 21:2000;1769-1775.
19. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M.et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435:2001;6-25.
20. Matsumura Y., Kitamura E., Miyoshi K., Yamamoto Y., Furuyama J., Sugihara T. Japanese siblings with missense mutation (717Val-Ile) in amyloid precursor protein of early onset Alzheimer's disease. Neurology. 46:1996;1721-1723.
21. Morley JE, Farr SA, Flood JF. Antibody to amyloid β protein alleviates impaired acquisition, retention and memory processing in SAMP8 mice. Neurobiol Learn Mem 2002;78:125-38.
22. Morley J.E., Kumar V.B., Bernardo A.E., Farr S.A., Uezu K., Tumosa N.et al. β-Amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides. 21:2000;1761-1767.
23. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain. Res. 827:1999;243-260.
24. Naslund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P.et al. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. J. Am. Med. Assoc. 283:2000;1571-1577.
25. Niimi M., Sato M., Taminato T. Neuropeptide Y in central control of feeding and interactions with orexin and leptin. Endocrine. 14(2):2001;269-273.
26. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G.et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18:1998;9996-10015.
27. Piper D.C., Upton N., Smith M.I., Hunter A.J. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur. J. Neurosci. 12:2000;726-730.
28. Rosenberg R.N. The molecular and genetic basis of AD: the end of the beginning. The 2000 Wartenberg lecture. Neurology. 54:2000;2045-2054.
29. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H.et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding and behavior. Cell. 92:1998;573-585.
30. Samson W.K., Gosnell B., Chang J.K., Resch Z.T., Murphy T.C. Cardiovascular regulatory actions of the hypocretins in brain. Brain. Res. 831(1-2):1999;248-253.
31. Younkin S.G. The amyloid protein precursor mutations linked to familial Alzheimer's disease alter processing in a way that fosters amyloid deposition. Tohoku. J. Exp. Med. 174:1994;217-223.